OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Traditional Chinese Medicine and Natural Products: Potential Approaches for Inflammatory Bowel Disease
Shuo Yuan, You Li, Jiao Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25

Showing 25 citing articles:

The progression of inorganic nanoparticles and natural products for inflammatory bowel disease
Qingrong Li, Liting Lin, Cong Zhang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21

Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles
Shi Wang, Hongliang He, Yu Mao, et al.
Advanced Science (2024) Vol. 11, Iss. 17
Open Access | Times Cited: 14

Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments
Yaxi Zhou, Diandian Wang, Wenjie Yan
Nutrients (2023) Vol. 15, Iss. 4, pp. 1031-1031
Open Access | Times Cited: 34

Quercetin serves as the major component of Xiang-lian Pill to ameliorate ulcerative colitis via tipping the balance of STAT1/PPARγ and dictating the alternative activation of macrophage
Haifeng Zhou, Chao Yang, Junyi Li, et al.
Journal of Ethnopharmacology (2023) Vol. 313, pp. 116557-116557
Closed Access | Times Cited: 22

Regulatory mechanism and therapeutic potentials of naringin against inflammatory disorders
Peng Yuan, Ruyi Qu, Shuqin Xu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24619-e24619
Open Access | Times Cited: 10

Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study
Huantian Cui, Yutong Jin, Ning Wang, et al.
Phytomedicine (2024) Vol. 128, pp. 155509-155509
Closed Access | Times Cited: 6

Unlocking the Medicinal Potential of Plant-Derived Extracellular Vesicles: current Progress and Future Perspectives
Xiaoliang Liu, Kecheng Lou, Y.‐H. Percival Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4877-4892
Open Access | Times Cited: 4

Protective Application of Chinese Herbal Compounds and Formulae in Intestinal Inflammation in Humans and Animals
Yang Yang, Gang Xiao, Pi Cheng, et al.
Molecules (2023) Vol. 28, Iss. 19, pp. 6811-6811
Open Access | Times Cited: 11

P-coumaric acid ameliorates Aβ25–35-induced brain damage in mice by modulating gut microbiota and serum metabolites
Bing Cao, Mengnan Zeng, Feng-xiao Hao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115825-115825
Open Access | Times Cited: 10

In-vitro and in-vivo evaluation and anti-colitis activity of esculetin-loaded nanostructured lipid carrier decorated with DSPE-MPEG2000
Feng Shi, Wenxiong Yin, Michael Adu‐Frimpong, et al.
Journal of Microencapsulation (2023) Vol. 40, Iss. 6, pp. 442-455
Closed Access | Times Cited: 8

Therapeutic Effects of Qingchang Tongluo Decoction on Intestinal Fibrosis in Crohn’s Disease: Network Pharmacology, Molecular Docking and Experiment Validation
Yanan Li, Jingyi Hu, Ryan Au, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 3269-3293
Open Access | Times Cited: 2

The aqueous extracts of Ageratum conyzoides inhibit inflammation by suppressing NLRP3 inflammasome activation
Zhen Xu, Rong Ji, Xiangru Zha, et al.
Journal of Ethnopharmacology (2023) Vol. 309, pp. 116353-116353
Closed Access | Times Cited: 6

Therapeutic Potential Evaluation of Silk Sericin Stabilized Fisetin to Ulcerative Colitis
Chunru Wang, Yingjie Xiang, Wenjie Ma, et al.
Macromolecular Bioscience (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 6

Tieguanyin extracts ameliorated DSS-induced mouse colitis by suppressing inflammation and regulating intestinal microbiota
Yuxi Zhang, Xinyu Feng, Haiyu Lin, et al.
Food & Function (2022) Vol. 13, Iss. 24, pp. 13040-13051
Closed Access | Times Cited: 9

Aloe-emodin alleviates inflammatory bowel disease in mice by modulating intestinal microbiome homeostasis via the IL-4/IL-13 axis
Dong Uk Yang, Tingrui Ge, Jingyi Zhou, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e34932-e34932
Open Access | Times Cited: 1

Linderanine C regulates macrophage polarization by inhibiting the MAPK signaling pathway against ulcerative colitis
Mengyao Lan, Cailu Lin, Lulu Zeng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117239-117239
Open Access | Times Cited: 1

Abdominal Pain in Inflammatory Bowel Disease-Epidemiology, Pathophysiology, and Management: A Narrative Review
W. D. Tan, Zi-xuan Liu, Xiaoyan Liu, et al.
Pain and Therapy (2024) Vol. 13, Iss. 6, pp. 1447-1469
Open Access | Times Cited: 1

Integrating 16S rRNA Sequencing, Microflora Metabolism, and Network Pharmacology to Investigate the Mechanism of SBL in Alleviating HDM-Induced Allergic Rhinitis
Peiting Li, Sharon Sze-Man Hon, Miranda Sin‐Man Tsang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8655-8655
Open Access

Pathogenesis and Treatment of Colitis-Associated Colorectal Cancer: Insights from Traditional Chinese Medicine
Yongxun Jin, Haizhao Liu, Yuhui Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119096-119096
Closed Access

Biological agents as attractive targets for inflammatory bowel disease therapeutics
Jia-Chen Xue, Xiao-Ting Hou, Yuwei Zhao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024), pp. 167648-167648
Open Access

Page 1

Scroll to top